<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" orientation="portrait" position="float">
 <label>TABLE 2</label>
 <caption>
  <title>Universal hepatitis C testing results at four urban emergency departments (EDs) — Birmingham, Alabama; Oakland, California; Baltimore, Maryland; and Boston, Massachusetts, 2015–2017</title>
 </caption>
 <table frame="hsides" rules="groups" width="6.493in">
  <col width="21%" span="1"/>
  <col width="21%" span="1"/>
  <col width="14%" span="1"/>
  <col width="15%" span="1"/>
  <col width="19%" span="1"/>
  <col width="10%" span="1"/>
  <thead>
   <tr>
    <th rowspan="2" valign="bottom" align="left" scope="col" colspan="1">Client and testing characteristic</th>
    <th valign="bottom" colspan="5" align="center" scope="colgroup" rowspan="1">Study sites and dates
     <hr/>
    </th>
   </tr>
   <tr>
    <th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1">University of Alabama at Birmingham Hospital, Birmingham, Alabama Oct 15, 2015–Feb 15, 2016</th>
    <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Highland Hospital, Oakland, California Oct 15, 2015–Feb 15, 2016</th>
    <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Johns Hopkins Hospital, Baltimore, Maryland May 1, 2016–Jul 31, 2016*</th>
    <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Boston University Medical Center, Boston, Massachusetts Nov 2, 2016–Feb 28, 2017</th>
    <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">All sites</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unique ED visitors
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">18,916
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">18,272
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">13,069
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">26,870
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">77,127
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Patients eligible for hepatitis C testing
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">13,999
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">9,585
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">7,639
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">12,284
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">43,507
     <sup>†</sup>
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Anti-HCV tests performed
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">5,973
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">2,900
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">1,638
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">3,741
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">14,252
     <sup>§</sup>
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total anti-HCV positive tests (%)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">459 (7.7)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">166 (5.7)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">120 (7.3)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">570 (15.2)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">1,315 (9.2)
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Adults born 1945–1965, positive test results for anti-HCV/anti-HCV tests (%)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">232/2,205 (10.5)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">98/713 (13.7)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">69/437 (15.8)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">288/1,585 (18.2)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">687/4,940 (13.9)
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Born after 1965, positive test results for anti-HCV/anti-HCV tests (%)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">227/3,768 (6.0)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">68/2,187 (3.1)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">51/1,201 (4.2%)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">282/2,156 (13.1)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">628/9,312 (6.7)
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total HCV RNA tests performed (%)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">398 (86.9)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">125 (75.3)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">38 (31.6)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">557 (97.7)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">1,118 (85)
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total current HCV infections (positive test results for HCV RNA) (%)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">252 (63.3)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">79 (63.2)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">27 (71.1)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">335 (60.1)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">693 (62.0)
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Estimated prevalence of positive results for HCV RNA (%)
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">4.9
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">3.6
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">5.2
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">9.1
     <hr/>
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">5.7
     <hr/>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" scope="row" rowspan="1" colspan="1">State and national estimated prevalence of positive results for HCV RNA, %</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Alabama, 0.85</td>
    <td valign="top" align="center" rowspan="1" colspan="1">California, 1.25</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Maryland, 1.00</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Massachusetts, 0.85</td>
    <td valign="top" align="center" rowspan="1" colspan="1">National, 0.93</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <bold>Abbreviations:</bold> anti-HCV = HCV antibody; EHR = electronic health record; HCV = hepatitis C virus.
  </p>
  <p>* Limited to a 3-month testing period because of programmatic changes occurring during the observation period.</p>
  <p>
   <sup>†</sup> Born after 1944, aged ≥18 years, medically or surgically stable, and no self-reported history of prior HCV infection.
  </p>
  <p>
   <sup>§</sup> Reasons testing not performed included that the patient declined testing or venipuncture was not performed because no diagnostic tests requiring venipuncture were ordered by the ED provider.
  </p>
 </table-wrap-foot>
</table-wrap>
